Authors response to comments on "Association of polypharmacy with clinical outcomes and healthcare utilization in older adults with cardiometabolic diseases: a retrospective cohort study"
机构:[1]Department of Pharmacy, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Disorders, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.首都医科大学宣武医院[2]Clinical Research Institute, Institute of Advanced Clinical Medicine, Peking University, Beijing, 100191, China.
第一作者机构:[1]Department of Pharmacy, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Disorders, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Su Su,Zhu Xuelu,Wu Shiqi,et al.Authors response to comments on "Association of polypharmacy with clinical outcomes and healthcare utilization in older adults with cardiometabolic diseases: a retrospective cohort study"[J].International Journal Of Clinical Pharmacy.2025,47(3):911-912.doi:10.1007/s11096-025-01918-y.
APA:
Su Su,Zhu Xuelu,Wu Shiqi,Ma Wenyao,Yan Suying&Zhang Lan.(2025).Authors response to comments on "Association of polypharmacy with clinical outcomes and healthcare utilization in older adults with cardiometabolic diseases: a retrospective cohort study".International Journal Of Clinical Pharmacy,47,(3)
MLA:
Su Su,et al."Authors response to comments on "Association of polypharmacy with clinical outcomes and healthcare utilization in older adults with cardiometabolic diseases: a retrospective cohort study"".International Journal Of Clinical Pharmacy 47..3(2025):911-912